Senior International Medical Digital Manager

Location: Ingelheim, Germany
Job Type: Full-Time
Employer: Boehringer Ingelheim
As Senior International Digital Medical Manager you will accelerate the adoption of digital within the specific Medical Therapeutic Area and live your passion of thinking outside of the box. You will be part of a dynamic team where you will have the opportunity to use your creative skills and digital mindset to provide a unique Boehringer Ingelheim customer experience.

Tasks & responsibilities

  • As Senior International Medical Digital Manager you create a plan to catalyse the medical digital transformation within the Therapeutic Area (TA) Oncology at Boehringer Ingelheim.
  • You will align with the Digital Manager and the Medical Affairs brand lead in order to ensure an optimal customer journey which is aligned with our brand and customer plans.
  • Furthermore, you will co-create the TA content to be innovative, cutting-edge and strategic as well as desirable and usable for the local country implementation, for example multi-channel content, videos, infographics and webinars.
  • In your new role you set key performance indicators to ensure measurability and the track user journey.
  • Last but not least you identify innovations that can evolve or transform the TA customer experience within the complex regulatory environment.

Requirements

  • Registered Medical Practitioner, Master of Science or PhD; experience in Therapeutic Areas/Oncology preferred
  • A minimum of 5 years of work experience regarding the following:
    • Significant medical experience within healthcare
    • Effective digital mindset to innovate, create the strategy and fully execute
    • Ability to implement new digital opportunities
    • Substantial experience in mix of local and international roles
    • Experience in a matrix organization and in cross-functional teams
  • Fluent English both written and spoken, German would be a plus

Apply for this job

About Boehringer Ingelheim
Innovative medicines for people and animals have for more than 130 years been what the research-driven pharmaceutical company Boehringer Ingelheim stands for. Boehringer Ingelheim is one of the pharmaceutical industry's top 20 companies and to this day remains family-owned. Day by day, some 50,000 employees create value through innovation for the three business areas human pharmaceuticals, animal health and biopharmaceutical contract manufacturing. In 2016, Boehringer Ingelheim achieved net sales of around 15.9 billion euros. With more than three billion euros, R&D expenditure corresponds to 19.6 per cent of net sales.

Social responsibility comes naturally to Boehringer Ingelheim. That is why the company is involved in social projects such as the "Making More Health" initiative. Boehringer Ingelheim also actively promotes workforce diversity and benefits from its employees' different experiences and skills. Furthermore, the focus is on environmental protection and sustainability in everything the company does.

Post your job offer now to start hiring the best eHealth talent! For further information, please contact us.

Most Popular Now

mHealth as Effective as Clinic-Based Int…

A mobile health (mHealth) intervention was found to be as effective as a clinic-based group intervention for people with serious mental illness in a new study published online in Psychiatric...

Mobile Health Technology can Potentially…

Mobile health technology has the potential to transform the way we prevent and manage heart disease, but there are unanswered questions about how to optimize this technology and maintain engagement...

New Computational Tool could Help Optimi…

Scientists have developed a novel computational approach that incorporates individual patients' brain activity to calculate optimal, personalized brain stimulation treatment for Alzheimer's disease. Lazaro Sanchez-Rodriguez of the University of Calgary...

First Call for Science and Technology at…

Participate in the first ever ESC Digital Health Call for Technology, for the chance to present your innovations, your technology or your products at ESC Congress 2018 in front of...

Siemens Healthineers Assists Swiss Post …

To expand its portfolio in the area of eHealth, Swiss Post will make use of the Siemens Healthineers eHealth Solutions(1) in the future. The eHealth solution offered by Swiss Post...

Philips Expands its Therapeutic Care Bus…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced that it has acquired Remote Diagnostic Technologies (RDT), a UK-based leading innovator of advanced solutions for the...

Joined-Up Health & Care Conference M…

InterSystems, a global leader in health information technology, will be celebrating a double anniversary at its annual Joined-Up Health & Care conference. This year’s event at The Belfry, Sutton Coldfield...

Ingestible 'Bacteria on a Chip' could He…

MIT researchers have built an ingestible sensor equipped with genetically engineered bacteria that can diagnose bleeding in the stomach or other gastrointestinal problems. This "bacteria-on-a-chip" approach combines sensors made from...

FDA Takes New Steps to Advance Digital H…

Today, the FDA is opening a docket to solicit feedback on important provisions of the 21st Century Cures Act ("Cures Act"). The Cures Act amended the Federal Food, Drug, and...

Mobile App for Autism Screening Yields U…

A Duke study of an iPhone app to screen young children for signs of autism has found that the app is easy to use, welcomed by caregivers and good at...

Open Call MSCA-IF-2018: Individual Fello…

The goal of the Individual Fellowships is to enhance the creative and innovative potential of experienced researchers, wishing to diversify their individual competence in terms of skill acquisition through advanced...

Lexmark Partners with NHS Shared Busines…

Lexmark, a global imaging solutions leader, today announced a partnership with NHS Shared Business Services (NHS SBS) to enable the public sector to utilise Lexmark technology to support their aim...